Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain MYOK message board posts where the ticker symbol MYOK has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest MYOK SEC Filings

Filings Format Description Filing Date File/Film Number
4/A  Documents [Amend] Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004465 Size: 18 KB
2018-02-16
4/A  Documents [Amend] Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004463 Size: 12 KB
2018-02-16
4/A  Documents [Amend] Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004462 Size: 11 KB
2018-02-16
5/A  Documents [Amend] Annual statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004461 Size: 25 KB
2018-02-16
4/A  Documents [Amend] Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004341 Size: 8 KB
2018-02-15
5  Documents Annual statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004054 Size: 20 KB
2018-02-14
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001144204-18-008874 (34 Act)  Size: 145 KB
2018-02-14 005-89169
18612404
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001193125-18-042756 (34 Act)  Size: 46 KB
2018-02-13 005-89169
18604402
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001193125-18-042538 (34 Act)  Size: 205 KB
2018-02-13 005-89169
18603480
5  Documents Annual statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-003668 Size: 5 KB
2018-02-13
More MYOK SEC Filings


Related news from
Wed, 14 Feb 2018
21:30:00 +0000
MyoKardia to Present at the RBC Capital Markets’ 2018 Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018-- MyoKardia, Inc., a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, ...
Wed, 14 Feb 2018
13:30:00 +0000
MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018-- MyoKardia, Inc., a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, ...
Fri, 19 Jan 2018
13:30:00 +0000
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018-- MyoKardia, Inc., a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, ...
Tue, 16 Jan 2018
20:50:12 +0000
Edited Transcript of MYOK earnings conference call or presentation 2-Nov-17 8:30pm GMT
Q3 2017 MyoKardia Inc Earnings Call
Wed, 10 Jan 2018
17:08:18 +0000
4 Biotechs with Near Term Catalysts: G1 Therapeutics, Inc. (GTHX), Sierra Oncology Inc (SRRA), Myokardia Inc (MYOK), Jounce Therapeutics (JNCE)
The company’s lead asset, Trilaciclib, is currently being evaluated in a number of settings as a tack-on to the standard of care in both front line and 2nd-3rd lines of small cell lung cancer (SCLC) and triple-negative breast cancer (TNBC). CDK4/6 keeps cells in stasis, known as the G1 phase of the cell cycle, rendering it difficult to undergo cell division.
Wed, 03 Jan 2018
21:30:00 +0000
MyoKardia to Present at 36th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018-- MyoKardia, Inc., a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, ...
Mon, 11 Dec 2017
12:25:08 +0000
MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : December 11, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for MyoKardia, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more <b>(Read more...)</b>
Wed, 08 Nov 2017
14:44:42 +0000
MyoKardia, Inc. – Value Analysis (NASDAQ:MYOK) : November 8, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives MyoKardia, Inc. a score of 71. Our analysis is based on comparing MyoKardia, Inc. with the following peers – OrganiGram Holdings Inc, Ohr Pharmaceutical, Inc., Oragenics, Inc. and OncoCyte Corp. (OGI-CA, OHRP-US, OGEN-US and OCX-US). Investment Outlook MyoKardia, Inc. has a fundamental score of 71 and has ... Read more <b>(Read more...)</b>
Tue, 07 Nov 2017
17:48:58 +0000
Myokardia Inc (MYOK) Q3:17 Update At First Glance
Shares of Myokardia Inc (NASDAQ:MYOK) are down nearly 3% Tuesday as investors digest the biotech firm's third-quarter financial results. The company reported Q3 EPS of $(0.42) in line with street consensus, and reflecting a total net loss for the quarter of $14.2 million. MyoKardia also provided an update on the company’s End-of-Phase 2 meeting with the FDA Division of Cardiovascular and Renal Products.  The meeting focused on MyoKardia’s proposed registration program for mavacamten (formerly MYK-461) in symptomatic, obstructive hypertrophic cardiomyopathy (oHCM).  MyoKardia is incorporating guidance from the FDA on study design elements and plans to proceed with the pivotal Phase 3 trial, EXPLORER-HCM, and a long-term extension study, as the key remaining studies in the mavacamten registration program.  The company anticipates dosing the first patient in EXPLORER-HCM in the second quarter of 2018.  Between now and study start, the company plans to review the final trial design with the FDA.
Mon, 06 Nov 2017
12:17:33 +0000
MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : November 6, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for MyoKardia, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more <b>(Read more...)</b>
Thu, 02 Nov 2017
21:54:17 +0000
MyoKardia reports 3Q loss
On a per-share basis, the South San Francisco, California-based company said it had a loss of 42 cents. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed ...
Thu, 12 Oct 2017
12:24:58 +0000
MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : October 12, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for MyoKardia, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more <b>(Read more...)</b>
Tue, 10 Oct 2017
15:39:03 +0000
ETFs with exposure to MyoKardia, Inc. : October 10, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to MyoKardia, Inc. Here are 5 ETFs with the largest exposure to MYOK-US. Comparing the performance and risk of MyoKardia, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more <b>(Read more...)</b>



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "The most important thing I have learned at VF in the last 3 years reading all you smart peoples posts is money management. This is usually not taught by our parents." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards